VEXAS Syndrome with an Improvement of Chest Shadows without Immunosuppressive Therapy

Read full text
Authors: Kazuki Tanaka, Akira Kawamura, Ryo Suzuki, Takumi Nagasaki, Takafumi Masuda, Kotaro Yamada, Ryuuichi Nakamura, Toshiya Hiramatsu, Norimichi Akiyama, Ayaka Maeda, Shun Matsuura, Yohei Kirino
+1 more Naoki Koshimizu
Cited by: 0
References: 21

Abstract

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is an acquired autoinflammatory disease caused by UBA1 variants. We report an 86-year-old man with high C-reactive protein levels, bicytopenia, and bilateral chest shadows. Bronchoalveolar lavage revealed an elevated lymphocyte count. Bone marrow vacuoles and a UBA1 (c.122T>C p.Met41Thr) variant with a high variant allele frequency (VAF) confirmed VEXAS. Although he refused treatment, chest shadows improved without immunosuppressive therapy and remained stable for two months, despite the persistence of systemic inflammatory symptoms and elevated C-reactive protein levels. This case highlights the clinical heterogeneity of VEXAS syndrome, demonstrating that pulmonary involvement can be self-limiting despite high VAF and atypical lavage findings, suggesting careful consideration of the treatment timing.

Fields of Study & Subjects

Immunodeficiency and Autoimmune Disorders Blood disorders and treatments Autoimmune and Inflammatory Disorders Research

Publication details

Journal / source
Internal Medicine
Volume
65
Issue
21
Pages
2923–2928
Publication date
16 March 2026
Language
EN